BDBM261620 (S)-4-(1-benzyl-3-(-trifluoromethyl)-1H-pyrazol-5-yl)-1-(2,2-diphenylacetyl)piperazine-2-carboxylic acid::US9708275, Compound 23

SMILES OC(=O)[C@@H]1CN(CCN1C(=O)C(c1ccccc1)c1ccccc1)c1cc(nn1Cc1ccccc1)C(F)(F)F

InChI Key InChIKey=QLPGTGHEHONDAP-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 261620   

TargetType-2 angiotensin II receptor(Human)
Novartis

US Patent
LigandPNGBDBM261620(US9708275, Compound 23 | (S)-4-(1-benzyl-3-(-trifl...)
Affinity DataIC50: 93.8nMAssay Description:120 μL membrane (5 mg protein/well) was incubated with 15 μL of [125I]-CGP42112A and 15 μL of compound at RT for 1.5 hrs.The binding r...More data for this Ligand-Target Pair
In DepthDetails
US Patent